BsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy

被引:21
作者
Cauci, Sabina [1 ]
Maione, Vincenzo [2 ]
Buligan, Cinzia [1 ,3 ]
Linussio, Martina [1 ]
Serraino, Diego [4 ]
Stinco, Giuseppe [1 ,3 ]
机构
[1] Univ Udine, Dept Med, I-33100 Udine, Italy
[2] Univ Hosp Brescia, Dermatol Clin, I-25123 Brescia, Italy
[3] Univ Hosp Udine, Dermatol Clin, I-33100 Udine, Italy
[4] CRO Aviano Natl Canc Inst, Unit Canc Epidemiol, I-33081 Aviano, Italy
关键词
1,25-DIHYDROXYVITAMIN D-3; SKIN-CANCER; GENE POLYMORPHISMS; CELL LINES; VDR; METAANALYSIS; COHORT; ASSOCIATION; POPULATION; VARIANTS;
D O I
10.20892/j.issn.2095-3941.2017.0064
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate whether vitamin D receptor gene (VDR) BsmI-rs1544410 and FokI-rs2228570 polymorphisms, smoking duration, and body mass index (BMI) are risk factors for cutaneous melanoma, especially metastatic melanoma. Methods: We studied 120 cutaneous melanoma cases [68 stage I and II non-metastatic melanoma (NMetM) patients, plus 52 Stage III and IV metastatic melanoma (MetM) patients], and 120 matching healthy controls from northeast Italy. VDR polymorphisms were measured by restriction fragment length polymorphism analysis. Absence or presence of BsmI and FokI restriction sites was denoted by "B" and "F" or by "b" and "f," respectively. Results: VDR-BsmI bb genotype was more frequent among MetM (32.7%) than among NMetM cases (13.2%), with odds ratio (OR)=3.18. Comparison of all melanoma patients vs healthy controls showed that the following biomarkers were at risk: >= 20 years of smoking (OR=2.43); >= 20 years of smoking combined with bb (OR=4.78), Bb+ bb (OR=2.30), Ff (OR=3.04), and Ff+ff (OR=3.08); obesity (BMI>30 kg/m(2)) alone (OR=3.54); and obesity combined with Bb+ bb (OR=3.52), Ff (OR=4.78), and Ff+ff (OR=6.56). Comparison of MetM vs NMetM patients revealed that the following biomarkers were at risk: >= 20 years of smoking (OR=2.39), >= 20 years of smoking combined with bb (OR=5.13), Bb+bb (OR=3.07), and Ff+ff (OR=2.66); and obesity combined with Bb+ bb (OR=5.27), Ff (OR=6.28), and Ff+ff (OR=9.18). Triple combination of >= 20 years of smoking, obesity, and Bb+ bb yielded OR=9.65 for melanoma patients vs healthy controls and OR=12.2 for MetM vs. NMetM patients. Conclusions: Risk factors for cutaneous MetM include two VDR polymorphisms combined with smoking duration and obesity. Results suggest gene-environment implications in melanoma susceptibility and severity. Future studies in larger cohorts and in subjects with different genetic background are warranted to extend our findings.
引用
收藏
页码:302 / 318
页数:17
相关论文
共 61 条
  • [1] AIRTUM, 2016, IT ASS CANC REG
  • [2] Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study
    Ambatipudi, Srikant
    Cuenin, Cyrille
    Hernandez-Vargas, Hector
    Ghantous, Akram
    Le Calvez-Kelm, Florence
    Kaaks, Rudolf
    Barrdahl, Myrto
    Boeing, Heiner
    Aleksandrova, Krasimira
    Trichopoulou, Antonia
    Lagiou, Pagona
    Naska, Androniki
    Palli, Domenico
    Krogh, Vittorio
    Polidoro, Silvia
    Tumino, Rosario
    Panico, Salvatore
    Bueno-de-Mesquita, Bas
    Peeters, Petra H. M.
    Quiros, Jose Ramon
    Navarro, Carmen
    Ardanaz, Eva
    Dorronsoro, Miren
    Key, Tim
    Vineis, Paolo
    Murphy, Neil
    Riboli, Elio
    Romieu, Isabelle
    Herceg, Zdenko
    [J]. EPIGENOMICS, 2016, 8 (05) : 599 - 618
  • [3] [Anonymous], 2010, REG TUM REG FRIUL VE
  • [4] [Anonymous], 2012, Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012
  • [5] Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015
    Arnold, M.
    Holterhues, C.
    Hollestein, L. M.
    Coebergh, J. W. W.
    Nijsten, T.
    Pukkala, E.
    Holleczek, B.
    Tryggvadottir, L.
    Comber, H.
    Bento, M. J.
    Diba, Ch. S.
    Micallef, R.
    Primic-Zakelj, M.
    Izarzugaza, M. I.
    Perucha, J.
    Marcos-Gragera, R.
    Galceran, J.
    Ardanaz, E.
    Schaffar, R.
    Pring, A.
    de Vries, E.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (09) : 1170 - 1178
  • [6] Obesity and cancer: An update of the global impact
    Arnold, Melina
    Leitzmann, Michael
    Freisling, Heinz
    Bray, Freddie
    Romieu, Isabelle
    Renehan, Andrew
    Soerjomataram, Isabelle
    [J]. CANCER EPIDEMIOLOGY, 2016, 41 : 8 - 15
  • [7] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [8] Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer
    Bikle, Daniel D.
    Oda, Yuko
    Tu, Chia-Ling
    Jiang, Yan
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 : 47 - 51
  • [9] Cutaneous melanoma frequencies and seasonal trend in 20 years of observation of a population characterised by excessive sun exposure
    Bonin, Serena
    Albano, Antonio
    di Meo, Nicola
    Gatti, Alessandro
    Stinco, Giuseppe
    Zanconati, Fabrizio
    Trevisan, Giusto
    [J]. RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 379 - 385
  • [10] Spatial analysis of incidence of cutaneous melanoma in the Friuli Venezia Giulia region in the period 1995-2005
    Cecconi, Lorenzo
    Busolin, Anna
    Barbone, Fabio
    Serraino, Diego
    Chiarugi, Alessandra
    Biggeri, Annibale
    Catelan, Dolores
    [J]. GEOSPATIAL HEALTH, 2016, 11 (01) : 21 - 30